🚨 The 2024 ESC Guidelines issued today, include a Class 1A recommendation for using IVUS or OCT imaging during PCI for anatomically complex lesions, such as left main stem, true bifurcations, and long lesions. These advanced imaging techniques, at the heart of what we do, are essential for providing unmatched precision in lesion assessment, vessel preparation, and stent placement. This new guidance represents a big step forward for intravascular imaging, and we're proud to be part of innovation that contributes to better patient outcomes. #Nipro #Cardiology #ESC2024 #PCI #IVUS #OCT #Imaging #WeAreNipro
Nipro Medical Corporation
Medical Equipment Manufacturing
Miami, Florida 34,274 followers
About us
Nipro Medical Corporation is a subsidiary of Nipro Corporation Japan, established in 1954 and a world-leader in healthcare with over 35,000 employees around the globe. We are committed to delivering innovative, high quality solutions in the form of renal, medical-surgical, and vascular products – with the ultimate goal of improving patient care and quality of life. This fundamental objective drives us to develop cutting-edge, value-added products for healthcare professionals that are safe, effective, and easy to use. As an integral part of a vast global manufacturing network, Nipro Medical Corporation is responsible for managing the sales, marketing, and business operations of North, Central, and South America – unified in our commitment to improving patient care and quality of life. Our North American division is located in New Jersey and addresses the needs of the United States and Canada. In addition to Nipro branded products, we provide OEM manufacturing solutions to some of the biggest names in the medical industry. We are Nipro – your link between patient and care.
- Website
-
https://www.nipro.com
External link for Nipro Medical Corporation
- Industry
- Medical Equipment Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Miami, Florida
- Type
- Public Company
- Specialties
- Custom Medical Manufacturing Solutions, Medical-Surgical Medical Devices, Renal Medical Devices, Vascular Access Medical Devices, Vascular, Renal, Hemodialysis, Hospital products, OEM, and Technical services & education
Locations
-
Primary
3150 NW 107th Ave
Miami, Florida 33172, US
-
200 Crossing Blvd.
Bridgewater, New Jersey 08807, US
Employees at Nipro Medical Corporation
Updates
-
🌟 Are you attending the RHA 2024 Annual Conference? Join us from September 18-20 at the JW Marriott Las Vegas Resort & Spa, Booth N°200. 🌟 Location: 221 N. Rampart Blvd. Las Vegas, NV 89145 Why Visit Us? ✅ Experience the Surdial DX Machine – Discover why it’s setting the industry standard with advanced features designed for superior patient care. ✅ Learn About Our Dialyzers – Get insights into why Nipro's Elisio and Cellentia dialyzers are leading the way in quality and performance. ✅ Meet Our Experts – Connect with our team and learn about the latest innovations in renal care. 📅 Schedule a Meeting 📅 Let's Connect! 🤝 Schedule time with our team during the event to explore how Nipro can support your dialysis needs by sending a request to [email protected]. We look forward to seeing you at RHA 2024n booth N°200! #NiproMedical #DialysisSolutions #RenalCare #HealthcareInnovation #RHA2024 #SurdialDX #Dialyzers #MedicalDevices #HealthcareExcellence #InnovationInHealthcare #WeAreNipro
-
We hope everyone had an incredible experience at the #AMP meeting in Chicago! Congratulations to Dr. Pradeep K. Nair, MD, FACC, FSCAI and his exceptional team for successfully completing a highly complex live case. The case featured our new Aperta NSE PTA Balloon and the advanced Makoto IVUS system, setting new standards in vascular care. We are deeply grateful to our distinguished panelists, Craig Walker, MD, S. Jay Mathews, MD, MS, FACC, FSCAI, Bret N. Wiechmann, and Fadi Saab, MD, FACC, FSCAI, FASE, for their invaluable insights and support during the case discussion. Your expertise continues to drive the field forward, inspiring us all to achieve greater heights. Thank you to everyone who participated and made this event a resounding success. Together, we are pushing the boundaries of what's possible in vascular intervention! #MedicalInnovation #VascularHealth #LiveCase #Teamwork #HealthcareExcellence #IVUS #Endovascular #AMP2024 #MedicalLeadership #Collaboration #HealthcareInnovation #WeAreNipro #Aperta
-
🌟 Exciting News! 🌟 We’re thrilled to announce that we will be showcasing our latest innovations and developments at four major events in the UK during the second half of 2024! 🎉 Come visit our booth to see our cutting-edge products, including the SureFuser elastomeric infusion pump. Stay tuned for more details on each event. We can’t wait to connect with you and share our advancements! 📅 Event Schedule: 1- Association of Anaesthetists annual congress, 25-27 September, Harrogate 2- 27th BOPA annual conference, 11-13 October, ICC Birmingham 3- Diabetes Professional Care, 15-16 October, London 4- UKONS annual conference, 15-16 November, Manchester #Innovation #Healthcare #MedicalDevices #SureFuser #UKEvents #StayTuned #VisitUs #WeAreNipro
-
Crack the code for vessel preparation! We're thrilled to announce the US launch of the Aperta NSE PTA Catheter at the upcoming Amputation Prevention Symposium (AMP) in Chicago. Join us at Booth #103 for a live case and expert discussion: "Precision Based Image-Guided Revascularization" on August 16th, from 12:15 to 1:15 PM. Let's revolutionize patient care together. #Innovation #Healthcare #VascularIntervention #Nipro
-
**Summer Work Environment:** #PROLL #PlayWithUS #Summer #WeAreNipro
This content isn’t available here
Access this content and more in the LinkedIn app
-
🌟 The recent NephroFlow R.20 Release Summit at iMEP Mechelen (institute of Medical Practice) was a resounding success! 🎉 We welcomed international product specialists eager to explore the latest in renal care. The R.20 release is a major milestone in our roadmap, introducing groundbreaking features like new analytics for population health management and quality indicators. These innovations will further empower healthcare providers who use NephroFlow with deeper insights and improved patient outcomes. Thank you to everyone who attended and contributed to this event. Together, we are shaping the future of renal care! 🌍💡 #NephroFlow #RenalCare #Innovation #Healthcare #PopulationHealthManagement #wearenipro
-
Two great live cases demonstrated at NCVH this week by Matthew Finn and Pradeep K. Nair, MD, FACC, FSCAI using Nipro Makoto Intravascular Imaging system. Intravascular ultrasound can be used for a variety of purposes, and with a 35-65 MHz extended bandwidth HD image we are able to help target precision-based therapy to patients with peripheral artery disease and vascular disease. #NCVH2024 #IVUS #peripheral
-
Congratulations to Dr. Finn and CIS. Great job team #Nipro Vascular #Aperta NSE PTA now available in the US market
Congratulations to Dr. Matthew Finn on being the first in the country to use the Aperta NSE™ PTA Balloon at the CIS Ambulatory Surgery Center in Gray, Louisiana! This scored balloon treats peripheral vascular disease in the legs and is designed for reduced balloon slipping, less dissections, and a greater luminal gain in the artery. #Wearenipro Craig Liss